Growing community of inventors

Brussels, Belgium

Pascale Boel

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Pascale Boel ↔ Thierry R Boon-Falleur (2 patents)Pascale Boel ↔ Pierre Van Der Bruggen (2 patents)Pascale Boel ↔ Pierre G Coulie (2 patents)Pascale Boel ↔ Jean-Christophe Renauld (2 patents)Pascale Boel ↔ Claude Wildmann (2 patents)Pascale Boel ↔ Thierry Boon-Falleur (1 patent)Pascale Boel ↔ Pierre Coulie (1 patent)Pascale BoelPascale Boel (2 patents)Thierry R Boon-FalleurThierry R Boon-Falleur (143 patents)Pierre Van Der BruggenPierre Van Der Bruggen (73 patents)Pierre G CouliePierre G Coulie (53 patents)Jean-Christophe RenauldJean-Christophe Renauld (31 patents)Claude WildmannClaude Wildmann (5 patents)Thierry Boon-FalleurThierry Boon-Falleur (4 patents)Pierre CouliePierre Coulie (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ludwig Institute for Cancer Research Limited (2 from 525 patents)

2. Pierre Van Der Bruggen (0 patent)

3. Thierry Boon-falleur (0 patent)

4. Pierre Coulie (0 patent)

5. Pascale Boel (0 patent)

6. Claude Wildmann (0 patent)

7. Jean-christophe Renauld (0 patent)


2 patents:

1. 6110694 - Methods for determining complexes of tumor rejection antigens and

2. 5877017 - Isolated nucleic acid molecule encoding peptides which form complexes

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/20/2025
Loading…